Quadrivalent meningococcal conjugate vaccines

Quadrivalent meningococcal conjugate vaccines

Show other versions (1)

<em>Neisseria meningitidis</em> is an important cause of bacterial meningitis and septicaemia with most disease caused by meningococci bearing serogroups A, B, C, Y and W-135 polysaccharides. Monovalent serogroup C conjugate vaccines have become established in the immunisation programmes...

Full description

Bibliographic Details
Main Authors:	Pace, D, Pollard, A, Messonier, N
Format:	Journal article
Language:	English
Published:	Elsevier 2009
Subjects:	Vaccinology Meningitis Paediatrics

Similar Items

Vaccine prevention of meningococcal disease, coming soon?
by: Morley, S, et al.
Published: (2001)

Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
by: Pollard, A, et al.
Published: (2009)

Vaccines against bacterial meningitis
by: Segal, S, et al.
Published: (2004)

Quadrivalent meningococcal conjugate vaccines.
by: Pace, D, et al.
Published: (2009)

Global epidemiology of meningococcal disease and vaccine efficacy
by: Pollard, A
Published: (2004)

A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase
by: Riddell, A, et al.
Published: (2007)

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
by: Pace, D, et al.
Published: (2007)

B cell responses to conjugate and polysaccharide meningococcal vaccines
by: Ramasamy, M
Published: (2012)

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial
by: Perrett, K, et al.
Published: (2010)

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
by: Pulickal, A, et al.
Published: (2007)

Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization
by: Vu, D, et al.
Published: (2006)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
by: Clutterbuck, E, et al.
Published: (2006)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
by: Blanchard-Rohner, G, et al.
Published: (2010)

Immunogenicity and safety of a low-dose diphtheria, tetanus and acelular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
by: Collins, C, et al.
Published: (2004)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
by: Ruggeberg, J, et al.
Published: (2007)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
by: Diggle, L, et al.
Published: (2006)

Public policy for meningococcal vaccination
by: J. Claire Cameron
Published: (2018-05-01)

Sustaining immunity after immunization against encapsulated bacteria
by: Blanchard-Rohner, G, et al.
Published: (2008)

Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria
by: Sadarangani, M, et al.
Published: (2011)

Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01)

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
by: Pace, D, et al.
Published: (2008)

Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal
by: Pulickal, A, et al.
Published: (2009)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
by: Snape, M, et al.
Published: (2006)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023-08-01)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
by: Snape, M, et al.
Published: (2008)

Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
by: Miguel Tregnaghi, et al.
Published: (2014-09-01)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
by: Pollard, A, et al.
Published: (2004)

What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries?
by: Scott, J, et al.
Published: (2008)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
by: Lee, Y, et al.
Published: (2006)

Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus.
by: Hoang, L, et al.
Published: (2005)

School-aged children: a reservoir for continued circulation of Haemophilus influenzae Type b in the United Kingdom
by: Oh, S, et al.
Published: (2008)

Current safety issues with quadrivalent meningococcal conjugate vaccines
by: Tanya R. Myers, et al.
Published: (2018-05-01)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
by: Lee, Y, et al.
Published: (2008)

W135 in Africa: origins, problems and perspectives
by: Kelly, D, et al.
Published: (2003)

Meningococcal vaccines: past, present, and future perspectives
by: Seyed Davar Siadat and Dariush Norouzian
Published: (2007-10-01)

Emergency management of meningococcal disease: eight years on
by: Pollard, A, et al.
Published: (2007)

Haemophilus influenzae type b conjugate vaccines
by: Kelly, D, et al.
Published: (2004)

Genetics determinants of vaccine responses
by: O'Connor, D
Published: (2014)

High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
by: O'Connor, D, et al.
Published: (2017)

An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine
by: Pavitra Keshavan, et al.
Published: (2018-10-01)